205 related articles for article (PubMed ID: 11179673)
1. Context-dependent Pax-5 repression of a PU.1/NF-kappaB regulated reporter gene in B lineage cells.
Linderson Y; French NS; Neurath MF; Pettersson S
Gene; 2001 Jan; 262(1-2):107-14. PubMed ID: 11179673
[TBL] [Abstract][Full Text] [Related]
2. Corecruitment of the Grg4 repressor by PU.1 is critical for Pax5-mediated repression of B-cell-specific genes.
Linderson Y; Eberhard D; Malin S; Johansson A; Busslinger M; Pettersson S
EMBO Rep; 2004 Mar; 5(3):291-6. PubMed ID: 14993928
[TBL] [Abstract][Full Text] [Related]
3. NF-kappa B and Oct-2 synergize to activate the human 3' Igh hs4 enhancer in B cells.
Sepulveda MA; Emelyanov AV; Birshtein BK
J Immunol; 2004 Jan; 172(2):1054-64. PubMed ID: 14707079
[TBL] [Abstract][Full Text] [Related]
4. BSAP can repress enhancer activity by targeting PU.1 function.
Maitra S; Atchison M
Mol Cell Biol; 2000 Mar; 20(6):1911-22. PubMed ID: 10688639
[TBL] [Abstract][Full Text] [Related]
5. Functional synergism of STAT6 with either NF-kappa B or PU.1 to mediate IL-4-induced activation of IgE germline gene transcription.
Stütz AM; Woisetschläger M
J Immunol; 1999 Oct; 163(8):4383-91. PubMed ID: 10510379
[TBL] [Abstract][Full Text] [Related]
6. Physiological activation of the IgH 3' enhancer in B lineage cells is not blocked by Pax-5.
Andersson T; Neurath MF; Grant PA; Pettersson S
Eur J Immunol; 1996 Oct; 26(10):2499-507. PubMed ID: 8898966
[TBL] [Abstract][Full Text] [Related]
7. Pax-5 (BSAP) recruits Ets proto-oncogene family proteins to form functional ternary complexes on a B-cell-specific promoter.
Fitzsimmons D; Hodsdon W; Wheat W; Maira SM; Wasylyk B; Hagman J
Genes Dev; 1996 Sep; 10(17):2198-211. PubMed ID: 8804314
[TBL] [Abstract][Full Text] [Related]
8. Assembling a gene regulatory network for specification of the B cell fate.
Medina KL; Pongubala JM; Reddy KL; Lancki DW; Dekoter R; Kieslinger M; Grosschedl R; Singh H
Dev Cell; 2004 Oct; 7(4):607-17. PubMed ID: 15469848
[TBL] [Abstract][Full Text] [Related]
9. NFE, a new transcriptional activator that facilitates p50 and c-Rel-dependent IgH 3' enhancer activity.
Linderson Y; Cross D; Neurath MF; Pettersson S
Eur J Immunol; 1997 Feb; 27(2):468-75. PubMed ID: 9045919
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the expression and function of the transcription factor PU.1 (Spi-1 proto-oncogene) between murine macrophages and B lymphocytes.
Ross IL; Dunn TL; Yue X; Roy S; Barnett CJ; Hume DA
Oncogene; 1994 Jan; 9(1):121-32. PubMed ID: 8302571
[TBL] [Abstract][Full Text] [Related]
11. The transcription factor NF-kappaB/p50 interacts with the blk gene during B cell activation.
Zwollo P; Rao S; Wallin JJ; Gackstetter ER; Koshland ME
J Biol Chem; 1998 Jul; 273(29):18647-55. PubMed ID: 9660839
[TBL] [Abstract][Full Text] [Related]
12. Roles of Ets proteins, NF-kappa B and nocodazole in regulating induction of transcription of mouse germline Ig alpha RNA by transforming growth factor-beta 1.
Shi MJ; Park SR; Kim PH; Stavnezer J
Int Immunol; 2001 Jun; 13(6):733-46. PubMed ID: 11369700
[TBL] [Abstract][Full Text] [Related]
13. HS1,2 enhancer regulation of germline epsilon and gamma2b promoters in murine B lymphocytes: evidence for specific promoter-enhancer interactions.
Laurencikiene J; Deveikaite V; Severinson E
J Immunol; 2001 Sep; 167(6):3257-65. PubMed ID: 11544313
[TBL] [Abstract][Full Text] [Related]
14. Multiple Ets factors and interferon regulatory factor-4 modulate CD68 expression in a cell type-specific manner.
O'Reilly D; Quinn CM; El-Shanawany T; Gordon S; Greaves DR
J Biol Chem; 2003 Jun; 278(24):21909-19. PubMed ID: 12676954
[TBL] [Abstract][Full Text] [Related]
15. Both PU.1 and nuclear factor-kappa B mediate lipopolysaccharide- induced HIV-1 long terminal repeat transcription in macrophages.
Lodie TA; Reiner M; Coniglio S; Viglianti G; Fenton MJ
J Immunol; 1998 Jul; 161(1):268-76. PubMed ID: 9647233
[TBL] [Abstract][Full Text] [Related]
16. Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines.
Arguello M; Sgarbanti M; Hernandez E; Mamane Y; Sharma S; Servant M; Lin R; Hiscott J
Oncogene; 2003 Feb; 22(7):964-73. PubMed ID: 12592383
[TBL] [Abstract][Full Text] [Related]
17. A three-protein-DNA complex on a B cell-specific domain of the immunoglobulin mu heavy chain gene enhancer.
Rao E; Dang W; Tian G; Sen R
J Biol Chem; 1997 Mar; 272(10):6722-32. PubMed ID: 9045705
[TBL] [Abstract][Full Text] [Related]
18. PU.1 is regulated by NF-kappaB through a novel binding site in a 17 kb upstream enhancer element.
Bonadies N; Neururer Ch; Steege A; Vallabhapurapu S; Pabst T; Mueller BU
Oncogene; 2010 Feb; 29(7):1062-72. PubMed ID: 19966852
[TBL] [Abstract][Full Text] [Related]
19. Secretory interleukin-1 receptor antagonist gene expression requires both a PU.1 and a novel composite NF-kappaB/PU.1/ GA-binding protein binding site.
Smith MF; Carl VS; Lodie T; Fenton MJ
J Biol Chem; 1998 Sep; 273(37):24272-9. PubMed ID: 9727052
[TBL] [Abstract][Full Text] [Related]
20. NF-kappaB/p50 and NF-kappaB/c-Rel differentially regulate the activity of the 3'alphaE-hsl,2 enhancer in normal murine B cells in an activation-dependent manner.
Zelazowski P; Shen Y; Snapper CM
Int Immunol; 2000 Aug; 12(8):1167-72. PubMed ID: 10917891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
